These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 12859998)
1. Restimulation of tumour-specific immunity in a patient with AML following injection with B7-1 positive autologous blasts. Hicks C; Cheung C; Lindeman R Leuk Res; 2003 Nov; 27(11):1051-61. PubMed ID: 12859998 [TBL] [Abstract][Full Text] [Related]
2. In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy. Orleans-Lindsay JK; Deru A; Craig JI; Prentice HG; Lowdell MW Clin Exp Immunol; 2003 Sep; 133(3):467-75. PubMed ID: 12930376 [TBL] [Abstract][Full Text] [Related]
3. CD80 (B7-1) expression on human acute myeloid leukaemic cells cultured with GM-CSF, IL-3 and IL-6. Hicks C; Keoshkerian E; Gaudry L; Lindeman R Cancer Immunol Immunother; 2001 Jun; 50(4):173-80. PubMed ID: 11459169 [TBL] [Abstract][Full Text] [Related]
4. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition. Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189 [TBL] [Abstract][Full Text] [Related]
5. Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells. Cardoso AA; Seamon MJ; Afonso HM; Ghia P; Boussiotis VA; Freeman GJ; Gribben JG; Sallan SE; Nadler LM Blood; 1997 Jul; 90(2):549-61. PubMed ID: 9226154 [TBL] [Abstract][Full Text] [Related]
7. Targeting of a B7-1 (CD80) immunoglobulin G fusion protein to acute myeloid leukemia blasts increases their costimulatory activity for autologous remission T cells. Notter M; Willinger T; Erben U; Thiel E Blood; 2001 May; 97(10):3138-45. PubMed ID: 11342441 [TBL] [Abstract][Full Text] [Related]
8. Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission. Whiteway A; Corbett T; Anderson R; Macdonald I; Prentice HG Br J Haematol; 2003 Feb; 120(3):442-51. PubMed ID: 12580958 [TBL] [Abstract][Full Text] [Related]
12. IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML. Chan L; Hardwick N; Darling D; Galea-Lauri J; Gäken J; Devereux S; Kemeny M; Mufti G; Farzaneh F Mol Ther; 2005 Jan; 11(1):120-31. PubMed ID: 15585413 [TBL] [Abstract][Full Text] [Related]
13. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens. Yi-qun Z; Joost van Neerven RJ; Kasran A; de Boer M; Ceuppens JL Int Immunol; 1996 Jan; 8(1):37-44. PubMed ID: 8671587 [TBL] [Abstract][Full Text] [Related]
14. Efficient generation of antileukemic autologous T cells by short-term culture and gamma-irradiation of myeloid leukemic cells. Vereecque R; Saudemont A; Depil S; Corm S; Andrieux J; Soenen-Cornu V; Quesnel B Cancer Immunol Immunother; 2004 Sep; 53(9):793-8. PubMed ID: 15098140 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody. Makrigiannis AP; Musgrave BL; Hoskin DW J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production. Soos JM; Ashley TA; Morrow J; Patarroyo JC; Szente BE; Zamvil SS Int Immunol; 1999 Jul; 11(7):1169-79. PubMed ID: 10383950 [TBL] [Abstract][Full Text] [Related]
17. Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy. Seko Y; Takahashi N; Ishiyama S; Nishikawa T; Kasajima T; Hiroe M; Suzuki S; Ishiwata S; Kawai S; Azuma M; Yagita H; Okumura K; Yazaki Y Circulation; 1998 Feb; 97(7):637-9. PubMed ID: 9495297 [TBL] [Abstract][Full Text] [Related]
18. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions. Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128 [TBL] [Abstract][Full Text] [Related]